Skip to main content
TipRanks
Go Ultimate75% OFF

Jacobson Pharma Corporation Limited (2633) Stock Statistics & Valuation Metrics

7 Followers

Total Valuation

Jacobson Pharma Corporation Limited has a market cap or net worth of HKD 1.75B. The enterprise value is HKD 3.03B.

Market Cap
HKD 1.75B
Enterprise Value
HKD 3.03B

Share Statistics

Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,000,221,000
Owned by Insiders
―
Owned by Institutions
0.13%

Financial Efficiency

Jacobson Pharma Corporation Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.77%.

Return on Equity (ROE)
0.13
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
8.77%
Return on Capital Employed (ROCE)
0.12
Revenue Per Employee
887.71K
Profits Per Employee
170.60K
Employee Count
1,768
Asset Turnover
0.44
Inventory Turnover
2.40

Valuation Ratios

The current PE Ratio of Jacobson Pharma Corporation Limited is 6.09. Jacobson Pharma Corporation Limited’s PEG ratio is 0.06.

PE Ratio
6.09
PS Ratio
1.17
PB Ratio
0.79
Price to FCF
9.18
Price to Operating Cash Flow
5.46
PEG Ratio
0.06

Income Statement

In the last 12 months, Jacobson Pharma Corporation Limited had revenue of 1.57B and earned 301.62M in profits. Earnings per share was 0.15.

Revenue
1.57B
Gross Profit
677.90M
Operating Income
353.18M
Pretax Income
362.63M
Net Income
301.62M
EBITDA
506.97M
Earnings Per Share (EPS)
0.15

Cash Flow

In the last 12 months, operating cash flow was 336.70M and capital expenditures -136.19M, giving a free cash flow of 200.52M billion.

Operating Cash Flow
336.70M
Free Cash Flow
200.52M
Free Cash Flow per Share
0.10

Dividends & Yields

Jacobson Pharma Corporation Limited pays an annual dividend of HKD 0.04, resulting in a dividend yield of 9.83%

Dividend Per Share
HKD 0.04
Dividend Yield
9.83%
Payout Ratio
50.99%
Free Cash Flow Yield
10.90%
Earnings Yield
16.39%

Stock Price Statistics

Beta
0.08
52-Week Price Change
-36.99%
50-Day Moving Average
0.95
200-Day Moving Average
1.06
Relative Strength Index (RSI)
35.20
Average Volume (3m)
287.63K

Important Dates

Jacobson Pharma Corporation Limited upcoming earnings date is Nov 24, 2026, TBA (Not Confirmed).

Last Earnings Date
Jun 23, 2026
Next Earnings Date
Nov 24, 2026
Ex-Dividend Date
Dec 01, 2025

Financial Position

Jacobson Pharma Corporation Limited as a current ratio of 1.37, with Debt / Equity ratio of 39.33%

Current Ratio
1.37
Quick Ratio
0.86
Debt to Market Cap
0.35
Net Debt to EBITDA
1.07
Interest Coverage Ratio
11.50

Taxes

In the past 12 months, Jacobson Pharma Corporation Limited has paid 61.01M in taxes.

Income Tax
61.01M
Effective Tax Rate
0.17

Enterprise Valuation

Jacobson Pharma Corporation Limited EV to EBITDA ratio is 4.56, with an EV/FCF ratio of 11.88.

EV to Sales
1.52
EV to EBITDA
4.56
EV to Free Cash Flow
11.88
EV to Operating Cash Flow
7.07

Balance Sheet

Jacobson Pharma Corporation Limited has HKD 369.86M in cash and marketable securities with HKD 910.90M in debt, giving a net cash position of -HKD 541.04M billion.

Cash & Marketable Securities
HKD 369.86M
Total Debt
HKD 910.90M
Net Cash
-HKD 541.04M
Net Cash Per Share
-HKD 0.27
Tangible Book Value Per Share
HKD 0.96

Margins

Gross margin is 43.19%, with operating margin of 23.43%, and net profit margin of 19.22%.

Gross Margin
43.19%
Operating Margin
23.43%
Pretax Margin
23.11%
Net Profit Margin
19.22%
EBITDA Margin
33.26%
EBIT Margin
23.47%

Analyst Forecast

The average price target for Jacobson Pharma Corporation Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-0.47%
EPS Growth Forecast
-0.40%

Scores

Smart Score
5
AI Score
70